EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 390 filers reported holding EXELIXIS INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $4,941,000 | +12.3% | 331,399 | -3.6% | 0.01% | 0.0% |
| Q3 2016 | $4,399,000 | +133.9% | 343,947 | +42.8% | 0.01% | +150.0% |
| Q2 2016 | $1,881,000 | +121.8% | 240,827 | +13.6% | 0.00% | +100.0% |
| Q1 2016 | $848,000 | -26.7% | 211,962 | +3.3% | 0.00% | 0.0% |
| Q4 2015 | $1,157,000 | -17.7% | 205,117 | -18.1% | 0.00% | -50.0% |
| Q3 2015 | $1,405,000 | +182.7% | 250,519 | +89.5% | 0.00% | +100.0% |
| Q2 2015 | $497,000 | +51.5% | 132,221 | +3.7% | 0.00% | – |
| Q1 2015 | $328,000 | +111.6% | 127,556 | +18.8% | 0.00% | – |
| Q4 2014 | $155,000 | -90.1% | 107,412 | -89.5% | 0.00% | -100.0% |
| Q3 2014 | $1,558,000 | -66.8% | 1,018,472 | -26.5% | 0.00% | -50.0% |
| Q2 2014 | $4,699,000 | +98.5% | 1,386,016 | +107.3% | 0.00% | +100.0% |
| Q1 2014 | $2,367,000 | -62.2% | 668,617 | -34.6% | 0.00% | -66.7% |
| Q4 2013 | $6,264,000 | -5.5% | 1,021,823 | -10.3% | 0.01% | -14.3% |
| Q3 2013 | $6,631,000 | +28.4% | 1,139,414 | +0.2% | 0.01% | +40.0% |
| Q2 2013 | $5,164,000 | – | 1,137,523 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $199,507,000 | 56.91% |
| Sargent Investment Group, LLC | 1,032,560 | $18,193,000 | 3.40% |
| Bellevue Group AG | 3,930,700 | $69,259,000 | 1.10% |
| CAPITAL MANAGEMENT CORP /VA | 231,880 | $4,086,000 | 1.04% |
| Orbimed Advisors | 3,753,700 | $66,140,000 | 0.94% |
| TEALWOOD ASSET MANAGEMENT INC | 121,848 | $2,147,000 | 0.90% |
| FARALLON CAPITAL MANAGEMENT LLC | 7,500,000 | $132,150,000 | 0.89% |
| Chicago Capital, LLC | 806,113 | $14,204,000 | 0.87% |
| Penn Capital Management Company, LLC | 456,587 | $8,045,000 | 0.84% |
| AJO, LP | 7,636,882 | $134,561,000 | 0.80% |